Longitudinal brain volumetric changes and their predictive effects on cognition among cognitively asymptomatic patients with Parkinson's disease

Parkinsonism and Related Disorders

Volumn 21, Issue 5, 2015, Pages 483-488

  Wen, Ming Ching ^a   Ng, Aloysius ^a   Chander, Russell Jude ^a   Au, Wing Lok ^a,b   Tan, Louis C S ^a,b   Kandiah, Nagaendran ^a,b  

^a NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

Frontal related dysfunction; Longitudinal study; Mild cognitive impairment; White matter

Indexed keywords

ADULT; AGED; ARTICLE; ASYMPTOMATIC DISEASE; BRAIN ATROPHY; BRAIN SIZE; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; DISEASE COURSE; FEMALE; FOLLOW UP; FRONTAL CORTEX; GRAY MATTER; HUMAN; LONGITUDINAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; PARIETAL CORTEX; PARKINSON DISEASE; PRIORITY JOURNAL; WHITE MATTER; BRAIN; CROSS-SECTIONAL STUDY; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; PSYCHOLOGY;

AGED; BRAIN; COGNITION; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GRAY MATTER; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; ORGAN SIZE; PARKINSON DISEASE; PREDICTIVE VALUE OF TESTS; WHITE MATTER;

EID: 84928590465     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2015.02.014     Document Type: Article

References (34)

1. Dauer W., Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003, 39:889-909.
2. Litvan I., Bhatia K.P., Burn D.J., Goetz C.G., Lang A.E., McKeith I., et al. Movement disorders society Scientific Issues Committee report: SIC task force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 2003, 18:467-486.
3. Weintraub D., Doshi J., Koka D., Davatzikos C., Siderowf A.D., Duda J.E., et al. Neurodegeneration across stages of cognitive decline in Parkinson disease. Arch Neurol 2011, 68:1562-1568.
4. Chaudhuri K.R., Healy D.G., Schapira A.H. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006, 5:235-245.
5. Ekman U., Eriksson J., Forsgren L., Mo S.J., Riklund K., Nyberg L. Functional brain activity and presynaptic dopamine uptake in patients with Parkinson's disease and mild cognitive impairment: a cross-sectional study. Lancet Neurol 2012, 11:679-687.
6. Yarnall A.J., Breen D.P., Duncan G.W., Khoo T.K., Coleman S.Y., Firbank M.J., et al. Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study. Neurology 2014, 82:308-316.
7. Caviness J.N., Driver-Dunckley E., Connor D.J., Sabbagh M.N., Hentz J.G., Noble B., et al. Defining mild cognitive impairment in Parkinson's disease. Mov Disord 2007, 22:1272-1277.
8. Hanganu A., Bedetti C., Jubault T., Gagnon J.F., Mejia-Constain B., Degroot C., et al. Mild cognitive impairment in patients with Parkinson's disease is associated with increased cortical degeneration. Mov Disord 2013, 28:1360-1369.
9. Melzer T.R., Watts R., MacAskill M.R., Pitcher T.L., Livingston L., Keenan R.J., et al. Grey matter atrophy in cognitively impaired Parkinson's disease. JNeurol Neurosurg Psychiatr 2012, 83:188-194.
10. Ellfolk U., Joutsa J., Rinne J.O., Parkkola R., Jokinen P., Karrasch M. Brain volumetric correlates of memory in early Parkinson's disease. JPark Dis 2013, 3:593-601.
11. Mak E., Zhou J., Tan L.C., Au W.L., Sitoh Y.Y., Kandiah N. Cognitive deficits in mild Parkinson's disease are associated with distinct areas of grey matter atrophy. JNeurol Neurosurg Psychiatr 2013, 85:576-580.
12. Lee J.E., Cho K.H., Song S.K., Kim H.J., Lee H.S., Sohn Y.H., et al. Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease. JNeurol Neurosurg Psychiatr 2014, 85:7-16.
13. Sunwoo M.K., Jeon S., Ham J.H., Hong J.Y., Lee J.E., Lee J.M., et al. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease. Eur J Neurol 2014, 21. 922-e50.
14. Lee S.H., Kim S.S., Tae W.S., Lee S.Y., Choi J.W., Koh S.B., et al. Regional volume analysis of the Parkinson disease brain in early disease stage: gray matter, white matter, striatum, and thalamus. AJNR Am J Neuroradiol 2011, 32:682-687.
15. Agosta F., Canu E., Stefanova E., Sarro L., Tomic A., Spica V., et al. Mild cognitive impairment in Parkinson's disease is associated with a distributed pattern of brain white matter damage. Hum Brain Mapp 2014, 35:1921-1929.
16. Cheng H.C., Ulane C.M., Burke R.E. Clinical progression in Parkinson disease and the neurobiology of axons. Ann Neurol 2010, 67:715-725.
17. Cronin-Golomb A. Parkinson's disease as a disconnection syndrome. Neuropsychol Rev 2010, 20:191-208.
18. Gelb D.J., Oliver E., Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999, 56:33-39.
19. Fahn S., Elton R.L. Unified Parkinsons disease rating scale 1987, members Up, Macmillan Healthcare Information, Florham Park, NJ.
20. Litvan I., Goldman J.G., Troster A.I., Schmand B.A., Weintraub D., Petersen R.C., et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: movement Disorder Society Task Force guidelines. Mov Disord 2012, 27:349-356.
21. Dalrymple-Alford J.C., MacAskill M.R., Nakas C.T., Livingston L., Graham C., Crucian G.P., et al. The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology 2010, 75:1717-1725.
22. Wechsler D. WAIS-IV technical and interpretive manual 2008, Pearson, San Antonio, TX.
23. D'Elia L.F., Satz P., Uchiyama C.Y., White T. Color trails test: professional manual 1996, Psychological Assessment Resources Inc., Florida.
24. Dubois B., Slachevsky A., Litvan I., Pillon B. The FAB: a frontal assessment battery at bedside. Neurology 2000, 55:1621-1626.
25. Sunderland T., Hill J.L., Mellow A.M., Lawlor B.A., Gundersheimer J., Newhouse P.A., et al. Clock drawing in Alzheimer's disease. A novel measure of dementia severity. JAm Geriatr Soc 1989, 37:725-729.
26. Graham D.P., Cully J.A., Snow A.L., Massman P., Doody R. The Alzheimer's Disease Assessment Scale-Cognitive subscale: normative data for older adult controls. Alzheimer Dis Assoc Disord 2004, 18:236-240.
27. Marquez de la Plata C.D., Yang F.G., Wang J.Y., Krishnan K., Bakhadirov K., Paliotta C., et al. Diffusion tensor imaging biomarkers for traumatic axonal injury: analysis of three analytic methods. JInt Neuropsychol Soc 2011, 17:24-35.
28. Ashburner J., Csernansk J.G., Davatzikos C., Fox N.C., Frisoni G.B., Thompson P.M. Computer-assisted imaging to assess brain structure in healthy and diseased brains. Lancet Neurol 2003, 2:79-88.
29. Hanganu A., Bedetti C., Degroot C., Mejia-Constain B., Lafontaine A.L., Soland V., et al. Mild cognitive impairment is linked with faster rate of cortical thinningin patients with Parkinson's disease longitudinally. Brain 2014, 137:1120-1129.
30. Williams-Gray C.H., Foltynie T., Brayne C.E., Robbins T.W., Barker R.A. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 2007, 130:1787-1798.
31. Gotham A.M., BR G., MC D. Frontal cognitive funciton in patients with Parkinson's disease 'on' and 'off' levodopa. Brain 1988, 111:299-321.
32. Poletti M., Bonuccelli U. Acute and chronic cognitive effects of levodopa and dopamine agonists on patients with Parkinson's disease: a review. Ther Adv Psychopharmacol 2013, 3:101-113.
33. Bell P.T., Gilat M., O'Callaghan C., Copland D.A., Frank M.J., Lewis S.J., et al. Dopaminergic basis for impairments in functional connectivity across subdivisions of the striatum in Parkinson's disease. Hum Brain Mapp 2014, 10.1002/hbm.22701.
34. Szewczyk-Krolikowski K., Menke R.A., Rolinski M., Duff E., Salimi-Khorshidi G., Filippini N., et al. Functional connectivity in the basal ganglia network differentiates PD patients from controls. Neurology 2014, 83:208-214.